Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

J Yang, A Griffin, Z Qiang, J Ren - Signal transduction and targeted …, 2022 - nature.com
Cancer is a major threat to human health. Among various treatment methods, precision
therapy has received significant attention since the inception, due to its ability to efficiently …

CD44-targeted nanocarrier for cancer therapy

P Kesharwani, R Chadar, A Sheikh, WY Rizg… - Frontiers in …, 2022 - frontiersin.org
Cluster of differentiation 44 (CD44) is a cell surface glycoprotein overexpressed in varieties
of solid tumors including pancreatic, breast, ovary, brain, and lung cancers. It is a multi …

[HTML][HTML] Towards principled design of cancer nanomedicine to accelerate clinical translation

M Souri, M Soltani, FM Kashkooli, MK Shahvandi… - Materials Today Bio, 2022 - Elsevier
Nanotechnology in medical applications, especially in oncology as drug delivery systems,
has recently shown promising results. However, although these advances have been …

Glutathione‐depleting organic metal adjuvants for effective NIR‐II photothermal immunotherapy

Y Chen, P He, D Jana, D Wang, M Wang… - Advanced …, 2022 - Wiley Online Library
Although photothermal immunotherapy (PTI) is a compelling strategy for tumor therapy, the
development of promising photothermal agents to overcome the insufficient immunogenicity …

Polymeric nanoparticle-based nanovaccines for cancer immunotherapy

Y Zhang, J Chen, L Shi, F Ma - Materials Horizons, 2023 - pubs.rsc.org
Therapeutic cancer vaccines, which are designed to amplify tumor-specific T cell responses,
have been envisioned as one of the most powerful tools for effective cancer immunotherapy …

Reactive X (where X= O, N, S, C, Cl, Br, and I) species nanomedicine

K Wang, W Mao, X Song, M Chen, W Feng… - Chemical Society …, 2023 - pubs.rsc.org
Reactive oxygen, nitrogen, sulfur, carbonyl, chlorine, bromine, and iodine species (RXS,
where X= O, N, S, C, Cl, Br, and I) have important roles in various normal physiological …

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies

Y Guo, F Gao, A Ahmed, M Rafiq, B Yu… - Journal of Materials …, 2023 - pubs.rsc.org
Immunotherapy is a new type of tumor treatment after surgery, radiotherapy and
chemotherapy, and can be used to manage and destroy tumor cells through activating or …

Recent progress in cancer immunotherapy: Overview of current status and challenges

M Darvishi, F Tosan, P Nakhaei, DA Manjili… - … -Research and Practice, 2023 - Elsevier
Cancer treatment is presently one of the most important challenges in medical science.
Surgery, chemotherapy, radiotherapy, or combining these methods is used to eliminate the …

Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances

G Niu, H Wang, Y Zhai, B Zhou, Y Kang, Z Pei, X Ji - Nano Today, 2024 - Elsevier
In recent years, in situ cancer vaccines, as an emerging cancer immunotherapy strategy,
have garnered considerable attention. This review comprehensively discusses the research …

A bispecific nanomodulator to potentiate photothermal cancer immunotherapy

L Zhou, B Feng, H Wang, D Wang, Y Li - Nano Today, 2022 - Elsevier
Photothermal therapy (PTT) has shown great potential in cancer treatment for inducing
photothermal ablation and eliciting immune responses. However, PTT-triggered antitumor …